News

Iran began its Covid-19 vaccination campaign on Tuesday using Russia's Sputnik V jab to fight the Middle East's deadliest outbreak of the illness. The first doses were given to doctors and nurses at Imam Khomeini hospital in the capital Tehran,...

Business intelligence platform Suppleye has launched a free tool to help pharmaceutical professionals stay on top of critical supply market news. Suppleye provides users with an intelligent resource to monitor key market news within the pharmaceutical sector and track sentiment....

Vir Biotechnology, Inc. announced the publication of new research characterizing a novel site of vulnerability on the SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus-2) spike protein – specifically the N-terminal domain (NTD). The study findings were made available online on...

Cytiva launches the “Exosome Challenge,” an industry challenge to overcome hurdles in exosome production and manufacturing. The challenge will focus on the standard workflow, in three focus areas: Cell engineering: Developing innovative technologies to engineer cell lines that can produce...

Avid Bioservices, Inc. and Humanigen, Inc. announced that they have entered into a manufacturing services agreement to expand production capacity for lenzilumab™, Humanigen’s therapeutic candidate in development for COVID-19. Lenzilumab is an anti-human granulocyte macrophage-colony stimulating factor (GM-CSF) monoclonal...

Novartis announced that asciminib, a novel investigational treatment specifically targeting the ABL myristoyl pocket (STAMP), has been granted Breakthrough Therapy designation (BTD) by the US FDA for the treatment of adult patients with Philadelphia chromosome-positive chronic myeloid leukemia (Ph+...

Thermo Fisher Scientific, the world leader in serving science, today launched its CE-IVD-Marked, Applied Biosystems TaqPath COVID–19 HT Kit that is compatible with the Amplitude platform. The high-throughput solution enables clinical and public health laboratories to efficiently test up...